PolyPid
PYPD
13 hedge funds and large institutions have $6.9M invested in PolyPid in 2025 Q1 according to their latest regulatory filings, with 1 funds opening new positions, 1 increasing their positions, 1 reducing their positions, and 2 closing their positions.
0% more repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 1
7% less funds holding
Funds holding: 14 → 13 (-1)
8% less capital invested
Capital invested by funds: $7.5M → $6.9M (-$608K)
11.37% less ownership
Funds ownership: 36.34% → 24.97% (-11%)
50% less first-time investments, than exits
New positions opened: 1 | Existing positions closed: 2
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
ACM
AIGH Capital Management
Baltimore,
Maryland
|
+$335K |
| 2 |
Citadel Advisors
Miami,
Florida
|
+$31.5K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SCM
Stonepine Capital Management
Bend,
Oregon
|
-$145K |
| 2 |
TWC
TD Waterhouse Canada
Toronto,
Ontario, Canada
|
-$2.37K |
| 3 |
UBS Group
Zurich,
Switzerland
|
-$12 |
PYPD Hedge Fund Activity: Q1 2025 in Review
13 of the 7,461 institutional investors tracked by Wall St. Rank reported a position in PolyPid (PYPD) for Q1 2025, worth a combined $6.9M — down 8.1% from $7.5M a quarter earlier.
Sellers outnumbered buyers: 2 funds closed out of PYPD and 1 opened new positions — a net loss of 1 holder — while 1 trimmed existing stakes and 1 added.
The largest buyer was AIGH Capital Management, adding an estimated $335K. The largest seller was Stonepine Capital Management, cutting an estimated $145K.
- 13 institutional investors held PolyPid (PYPD) as of Q1 2025, down from 14 in Q4 2024.
- Funds reported $6.9M of PolyPid stock for Q1 2025, down 8.1% quarter-over-quarter.
- 1 fund opened new PolyPid positions in Q1 2025 and 2 closed out, a net change of -1 holder.
- The largest PolyPid buyer in Q1 2025 was AIGH Capital Management, an estimated $335K added.
- The largest PolyPid seller in Q1 2025 was Stonepine Capital Management, an estimated $145K sold.
Based on aggregated 13F filings for Q1 2025.